ArticleFrontiers in oncology2026
Case Report: CT-guided biopsy of a mediastinal mass in the visceral compartment.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The pathological diagnosis of mediastinal lesions is crucial for precision oncology. While endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the preferred minimally invasive method for visceral mediastinal lesions, its diagnostic yield can be limited for high-risk lesions surrounded by great vessels. This case demonstrates that under such complex anatomical constraints, a meticulously planned CT-guided percutaneous biopsy serves as a safe and effective alternative. Case presentation: A middle-aged male patient was highly suspected of having lung cancer with mediastinal metastasis based on clinical and radiological findings. Two successive bronchoscopic biopsies of the pulmonary lesion failed to yield a diagnosis. Although the medical team recommended EBUS-TBNA at a tertiary hospital, the patient opted for a CT-guided biopsy at our institution after considering personal convenience and economic factors. The target was a high-risk mediastinal lymph node located within the vascular "core area" between the aorta and superior vena cava. Intervention and outcome: Preprocedural planning with contrast-enhanced CT simulated three potential trajectories (transcostochondral, transsternal, transpulmonary). The transsternal approach was prioritized to avoid lung parenchyma, thereby eliminating the risk of pneumothorax-a critical consideration given the patient's comorbid emphysema and bullae. The initial transcostochondral approach was abandoned due to pain upon vascular contact and restricted maneuverability. The subsequent transsternal approach was successfully performed using a coaxial biopsy system to navigate the narrow vascular space, followed by tract embolization upon needle withdrawal. The procedure was safe, with only minimal, self-resolving mediastinal emphysema. Adequate tissue cores were obtained, enabling a definitive diagnosis of metastatic lung adenocarcinoma. Conclusion: For complex mediastinal lesions where standard approaches are unsuitable or declined by the patient, a meticulously planned CT-guided percutaneous biopsy based on three-dimensional anatomical assessment is a feasible and valuable diagnostic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.